Literature DB >> 6127059

Hepatitis B virus infection in patients with rheumatic diseases.

H Permin, J Aldershvile, J O Nielsen.   

Abstract

Two hundred and thirty-nine patients with different rheumatic diseases were investigated for serological markers of hepatitis B virus (HBV) infection. An increased prevalence of anti-HBs was found in patients with systemic lupus erythematosus. The total prevalence of HBV markers in patients with polymyalgia rheumatica, temporal arteritis, juvenile and adult rheumatoid arthritis (RA) and systemic sclerosis was not significantly different from age-matched controls. Remarkably, 6 patients were HBsAg-positive of whom 3 had RA (4%). Two patients with RA were "healthy' HBsAg carriers. The third patient had circulating HBeAg as well and had shown progression from acute hepatitis to cirrhosis during the time of observation. Three of 18 patients with polyarteritis nodosa were HBsAg- and HBeAg-positive, and all 3 were young men. Clinical improvement was seen in one of these patients and was associated with seroconversion from HBeAg to anti-HBe. Our data do not support the theory that HBV is an aetiological factor in rheumatic diseases except in some cases of polyarteritis nodosa.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127059      PMCID: PMC1001026          DOI: 10.1136/ard.41.5.479

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

3.  Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.

Authors:  R A Hawkes; C R Boughton; D R Schroeter; R H Decker; L R Overby
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

4.  Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.

Authors:  P H Bridgeford; M Lowenstein; T S Bocanegra; F B Vasey; B F Germain; L R Espinoza
Journal:  Arthritis Rheum       Date:  1980-04

5.  Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis.

Authors:  J Aldershvile; G G Frösner; J O Nielsen; F Hardt; F Deinhardt; P Skinhøj
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

6.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  G Realdi; A Alberti; M Rugge; F Bortolotti; A M Rigoli; F Tremolada; A Ruol
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

7.  The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.

Authors:  B A Runyon; D R LaBrecque; S Anuras
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

8.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis.

Authors:  A P Kirk; S Jain; S Pocock; H C Thomas; S Sherlock
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

9.  Hepatitis B e antibody determination: comparison and evaluation of four different methods.

Authors:  J Aldershvile; B Caspani; G G Frösner
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Hepatitis B virus and polymyalgia rheumatica: a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb.

Authors:  H Elling; P Skinhøj; P Elling
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

View more
  10 in total

1.  Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; You-Chen Chao; Chien-Lin Chen
Journal:  Hepatol Int       Date:  2018-11-14       Impact factor: 6.047

Review 2.  Hepatitis B virus (HBV) and autoimmune disease.

Authors:  Ram Maya; M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

3.  High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

Authors:  S Mouritsen; E Demant; H Permin; A Wiik
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

4.  Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China.

Authors:  Jijun Zhao; Minli Qiu; Meirong Li; Caisheng Lu; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

5.  Hepatitis B carrier state among SLE patients: case-control study.

Authors:  Omer Gendelman; Naim Mahroum; Doron Comaneshter; Pnina Rotman-Pikielny; Arnon D Cohen; Howard Amital; Michael Sherf
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 6.  Diagnosis of Liver Involvement in Primary Sjögren Syndrome.

Authors:  Pilar Brito Zeron; Soledad Retamozo; Albert Bové; Belchin Adriyanov Kostov; Antoni Sisó; Manuel Ramos-Casals
Journal:  J Clin Transl Hepatol       Date:  2013-12-15

7.  Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in taiwan.

Authors:  Fu-Hsiung Su; Chien-Sheng Wu; Fung-Chang Sung; Shih-Ni Chang; Chien-Tien Su; Ying-Hua Shieh; Chih-Ching Yeh
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

8.  Hepatitis B Serology in Patients with Rheumatic Diseases.

Authors:  Martin Feuchtenberger; Arne Schäfer; Axel Philipp Nigg; Michael Rupert Kraus
Journal:  Open Rheumatol J       Date:  2016-08-31

9.  The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis.

Authors:  Chan-Juan Zou; Lang-Jing Zhu; Yan-Hua Li; Ying-Qian Mo; Dong-Hui Zheng; Jian-Da Ma; Xia Ou-Yang; Frank Pessler; Lie Dai
Journal:  Clin Rheumatol       Date:  2013-01-23       Impact factor: 3.650

10.  Association of Rheumatoid Arthritis and Hepatitis B Infection: A Nationwide Nested Case-Control Study From 1999 to 2009 in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; Hans Hsienhong Lin; Chien-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.